JSC Kalceks launches Midazolam 5 mg/ml solution for injections
JSC Kalceks starts production and commercialization of Midazolam 5 mg/ml solution for injections. Product has been registered via decentralized registration procedure involving 9 European Union countries. First sales are expected in Latvia and Hungary following by other EU countries.
Medicinal product contains active ingredient Midazolam and is used to induce sedation (a state of calm, drowsiness or sleep) and relieves anxiety and muscle tension.
Midazolam 5 mg/ml is a third new product that Kalceks launches within this year.